Pizzella K M, Moore M C, Schultz R W, Walshe J, Schentag J J
Ther Drug Monit. 1980;2(3):273-81. doi: 10.1097/00007691-198007000-00011.
Dialysis clearance of cimetidine in patients receiving peritoneal dialysis, hemodialysis, and hemoperfusion was compared in stable and seriously ill patients. Two methods of determining dialysis clearance were employed, one of which was the method employed for cimetidine previously in the literature. Cimetidine clearance was lowest for peritoneal dialysis (5 ml/min), intermediate for hemodialysis (28 ml/min), and greatest for hemoperfusion (85 ml/min). Using both methods to calculate dialysis clearance, we found that cimetidine clearance during dialysis has been overestimated. In addition, pharmacokinetic analysis revealed that peritoneal and hemodialysis apparently removed cimetidine from the central compartment only, whereas hemoperfusion apparently removed drug from the peripheral compartment as well. A possible mechanism to explain this difference is based on the observation that hemodynamic changes occur during hemodialysis that may not be seen during hemoperfusion. No dosage adjustment need be made when patients receiving cimetidine undergo any form of dialysis; hemoperfusion may be of some benefit in removing drug from the central as well as tissue compartments in an acute overdose situation.
在病情稳定和重症患者中,比较了接受腹膜透析、血液透析和血液灌流的患者对西咪替丁的透析清除率。采用了两种测定透析清除率的方法,其中一种是先前文献中用于西咪替丁的方法。腹膜透析的西咪替丁清除率最低(5毫升/分钟),血液透析居中(28毫升/分钟),血液灌流最高(85毫升/分钟)。使用两种方法计算透析清除率后,我们发现透析期间西咪替丁的清除率被高估了。此外,药代动力学分析显示,腹膜透析和血液透析显然仅从中枢室清除西咪替丁,而血液灌流显然也从外周室清除药物。解释这种差异的一种可能机制基于以下观察结果:血液透析期间会发生血流动力学变化,而血液灌流期间可能看不到这种变化。接受西咪替丁治疗的患者进行任何形式的透析时均无需调整剂量;在急性过量情况下,血液灌流可能有助于从中枢室以及组织室清除药物。